Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0275 USD | +175.00% |
|
0.00% | +27,400.00% |
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 4 | 100.0 % | 2 | 100.0 % | -56.22% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 2 | 100.0 % | -56.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07/08/07 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/98/01 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01/98/01 |
Albert Brzeczko
PRN | Corporate Officer/Principal | 67 | 01/09/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/98/01 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01/98/01 |
William Skelly
BRD | Director/Board Member | 73 | 01/96/01 |
Director/Board Member | 53 | 01/02/01 | |
George Ross
BRD | Director/Board Member | 82 | 01/08/01 |
Robert Jones
CEO | Chief Executive Officer | 65 | 07/08/07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,001,783 | 10,081,080 ( 15.27 %) | 0 | 15.27 % |
Company contact information
Acura Pharmaceuticals, Inc.
616 N. North Court Suite 120
60067, Palatine
+847 705 7709
http://www.acurapharm.com![address Acura Pharmaceuticals, Inc.(ACUR)](https://cdn.zonebourse.com/static/address/120789192.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+27,400.00% | 1.82M | |
+16.13% | 122B | |
+19.65% | 115B | |
+21.22% | 26.64B | |
-23.84% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.28% | 15.49B | |
+63.81% | 14.83B | |
+1.94% | 13.67B |
- Stock Market
- Equities
- ACUR Stock
- Company Acura Pharmaceuticals, Inc.